You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for New Drug Application (NDA): 021175


✉ Email this page to a colleague

« Back to Dashboard


NDA 021175 describes ATNAA, which is a drug marketed by Us Army and is included in one NDA. It is available from one supplier. Additional details are available on the ATNAA profile page.

The generic ingredient in ATNAA is atropine; pralidoxime chloride. There are twenty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the atropine; pralidoxime chloride profile page.
Summary for 021175
Tradename:ATNAA
Applicant:Us Army
Ingredient:atropine; pralidoxime chloride
Patents:0
Suppliers and Packaging for NDA: 021175
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATNAA atropine; pralidoxime chloride INJECTABLE;INTRAMUSCULAR 021175 NDA Meridian Medical Technologies, LLC 11704-777 11704-777-01 1 KIT in 1 CARTON (11704-777-01) * .7 mL in 1 SYRINGE, GLASS * 2 mL in 1 SYRINGE, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INTRAMUSCULARStrength2.1MG/0.7ML;600MG/2ML
Approval Date:Jan 17, 2002TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.